These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 12203858
1. Naked nuclei revisited: p63 Immunoexpression. Reis-Filho JS, Albergaria A, Milanezi F, Amendoeira I, Schmitt FC. Diagn Cytopathol; 2002 Sep; 27(3):135-8. PubMed ID: 12203858 [Abstract] [Full Text] [Related]
2. Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: an analysis of 82 samples. Reis-Filho JS, Milanezi F, Amendoeira I, Albergaria A, Schmitt FC. Cancer; 2003 Jun 25; 99(3):172-9. PubMed ID: 12811858 [Abstract] [Full Text] [Related]
3. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Barbareschi M, Pecciarini L, Cangi MG, Macrì E, Rizzo A, Viale G, Doglioni C. Am J Surg Pathol; 2001 Aug 25; 25(8):1054-60. PubMed ID: 11474290 [Abstract] [Full Text] [Related]
6. p63 Expression of clear myoepithelial cells in epithelial-myoepithelial carcinoma of the salivary gland: a useful marker for naked myoepithelial cells in cytology. Kawahara A, Harada H, Yokoyama T, Kage M. Cancer; 2005 Aug 25; 105(4):240-5. PubMed ID: 15959915 [Abstract] [Full Text] [Related]
8. p63 expression profile in normal and malignant prostate epithelial cells. Davis LD, Zhang W, Merseburger A, Young D, Xu L, Rhim JS, Moul JW, Srivastava S, Sesterhenn IA. Anticancer Res; 2002 Aug 25; 22(6C):3819-25. PubMed ID: 12553000 [Abstract] [Full Text] [Related]
9. Myoepithelial cell cocktail (p63+SMA) for the evaluation of sclerosing breast lesions. Pavlakis K, Zoubouli C, Liakakos T, Messini I, Keramopoullos A, Athanassiadou S, Kafousi M, Stathopoulos EN. Breast; 2006 Dec 25; 15(6):705-12. PubMed ID: 16384708 [Abstract] [Full Text] [Related]
12. p63 expression profiles in human normal and tumor tissues. Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV, Teruya-Feldstein J, Pohar K, Hoos A, Cordon-Cardo C. Clin Cancer Res; 2002 Feb 25; 8(2):494-501. PubMed ID: 11839669 [Abstract] [Full Text] [Related]
13. p63 expression in benign and malignant breast lesions. Stefanou D, Batistatou A, Nonni A, Arkoumani E, Agnantis NJ. Histol Histopathol; 2004 Apr 25; 19(2):465-71. PubMed ID: 15024707 [Abstract] [Full Text] [Related]
15. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Weinstein MH, Signoretti S, Loda M. Mod Pathol; 2002 Dec 25; 15(12):1302-8. PubMed ID: 12481011 [Abstract] [Full Text] [Related]
16. Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63. O'Connell JT, Mutter GL, Cviko A, Nucci M, Quade BJ, Kozakewich HP, Neffen E, Sun D, Yang A, McKeon FD, Crum CP. Gynecol Oncol; 2001 Jan 25; 80(1):30-6. PubMed ID: 11136566 [Abstract] [Full Text] [Related]
17. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms. Ramalho LN, Ribeiro-Silva A, Cassali GD, Zucoloto S. Vet Pathol; 2006 Jul 25; 43(4):424-9. PubMed ID: 16846983 [Abstract] [Full Text] [Related]